In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice

Drug Delivery

Volumn 20, Issue 3-4, 2013, Pages 127-133

  Jin, Meihua ^a   Shen, Xuesong ^a   Zhao, Chunxia ^a   Qin, Xuelian ^a   Liu, Hanfu ^a   Huang, Lifang ^a   Qiu, Zhuangping ^a   Liu, Yi ^b  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Artesunate; Hepatocellular carcinoma; HepG 2 cells; Nanoliposomes

Indexed keywords

ARTESUNATE;

ANIMAL CELL; ANISOTROPY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY TEST; FLUORESCENCE POLARIZATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; ARTEMISIA; ARTEMISININS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEP G2 CELLS; HUMANS; LIPOSOMES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84879028743     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.801047     Document Type: Article

References (26)

1. Alizadeh D, Zhang L, Hwang J, et al. (2010). Tumor-Associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. Nanomedicine 6:382-90
2. Bar-On O, Shapira M, Hershko DD. (2007). Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells. Anticancer Drugs 18:1113-21 (Pubitemid 47480736)
3. Carmona-Ribeiro AM. (2003). Bilayer-forming synthetic lipids: Drugs or carriers? Curr Med Chem 10:2425-46 (Pubitemid 37236397)
4. Chernysh S, Irina K, Irina A. (2012). Anti-Tumor activity of immunomodulatory peptide alloferon-1 in mouse tumor transplantation model. Int Immunopharmacol 12:312-14
5. De Palma M, Naldini L. (2009). Tie2-expressing monocytes (TEMs): Novel targets and vehicles of anticancer therapy? Biochim Biophys Acta 1796:5-10
6. Dell'Eva R, Pfeffer U, Vene R, et al. (2004). Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the antimalarial artesunate. Biochem Pharmacol 68:2359-66 (Pubitemid 39535108)
7. Donnelly RF, Raj Singh TR, Woolfson AD. (2010). Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety. Drug Deliv 17:187-207
8. Efferth T, Dunstan H, Sauerbrey A. (2001). The anti-malarial artesunate is also active against cancer. Int J Oncol 18:767-73
9. Efferth T, Li PC, Konkimalla VS, Kaina B. (2007). From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13: 353-61 (Pubitemid 47126989)
10. Gao XM, Yu T, Cui MZ, et al. (2012). Identification and evaluation of apoptotic compounds from Garcinia oligantha. Bioorg Med Chem Lett 22:2350-3
11. Gordi T, Lepist EI. (2004). Artemisinin derivatives: Toxic for laboratory animals, safe for humans? Toxicol Lett 147:99-107 (Pubitemid 38130178)
12. Han LP, Huang Q, Zeng LY, et al. (2009). Recent progress in antimalarial mode of action of artemisinin and its derivatives. Prog Nat Sci 19:25-32
13. Krishna S, Bustamante L, Haynes RK, Staines HM. (2008). Artemisinins: Their growing importance in medicine. Trends Pharmacol Sci 29:520-7
14. Li S, Liu Y, Liu T, et al. (2011). Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique. Int J Pharm 411:172-7
15. Li Y, Shan F, Wu JM, et al. (2001). Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg Med Chem Lett 11:5-8 (Pubitemid 32006112)
16. Lu L, Kanwar J, Schmitt S, et al. (2011). Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant ''Thunder God Viné'. Anticancer Res 31:1-10
17. Mandal AK, Das S, Basu MK, et al. (2007). Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis. J Pharmacol Exp Ther 320:994-1001 (Pubitemid 46294072)
18. Morrissey C, Gallis B, Solazzi JW, et al. (2010). Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells. Anticancer Drugs 21:423-32
19. Reske T, Fulciniti M, Munshi NC. (2010). Mechanism of action of immunomodulatory agents in multiple myeloma. Med Oncol 27: 7-13
20. Reznikov AG, Chaykovskaya LV, Polyakova LI, et al. (2011). Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts. Exp Oncol 33:231-4
21. Sahoo SK, Parveen S, Panda JJ. (2007). The present and future of nanotechnology in human health care. Nanomedicine 3:20-31 (Pubitemid 46428187)
22. Shen X, Xu W, Jin M. (2011). An in vivo pharmacokinetic study of artemisinin-based nanoliposomes in nude mice. [J]. Lishizhen Med Materia Med Res 22:384-6 (In Chinese
23. Shen XS, Su Q, Qiu ZP, et al. (2010). Effects of artemisinin derivative on the growth metabolism of Tetrahymena thermophila BF5 based on expression of thermokinetics. Biol Trace Elem Res 136: 117-25
24. Skidan I, Miao B, Thekkedath RV, et al. (2009). In vitro cytotoxicity of novel pro-Apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL. Drug Deliv 16: 45-51
25. Wang CZ, Li XL, Wang QF, et al. (2009). The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep 21:577-84
26. Zhang JF, Liu JJ, Lu MQ, et al. (2007). Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro. Transpl Immunol 17:162-8